| Primary |
| Acute Promyelocytic Leukaemia |
32.2% |
| Myelodysplastic Syndrome |
32.2% |
| Acute Myeloid Leukaemia |
14.4% |
| Glioblastoma Multiforme |
3.3% |
| Myelofibrosis |
3.3% |
| Lung Neoplasm Malignant |
2.8% |
| Multiple Myeloma |
2.2% |
| Anaplastic Astrocytoma |
1.7% |
| Glioblastoma |
1.1% |
| Small Cell Lung Cancer |
1.1% |
| Small Cell Lung Cancer Stage Unspecified |
1.1% |
| Adult T-cell Lymphoma/leukaemia |
0.6% |
| Brain Oedema |
0.6% |
| Brain Stem Glioma |
0.6% |
| Metastatic Renal Cell Carcinoma |
0.6% |
| Non-small Cell Lung Cancer |
0.6% |
| Pain |
0.6% |
| Prophylaxis |
0.6% |
| Retinoic Acid Syndrome |
0.6% |
|
| White Blood Cell Count Decreased |
16.7% |
| Pyrexia |
6.7% |
| Renal Failure Acute |
6.7% |
| Vomiting |
6.7% |
| White Blood Cell Count Increased |
6.7% |
| Pneumonia |
5.0% |
| Respiratory Failure |
5.0% |
| Sinus Tachycardia |
5.0% |
| Ventricular Extrasystoles |
5.0% |
| Anaphylactic Reaction |
3.3% |
| Bone Marrow Necrosis |
3.3% |
| Cerebral Haemorrhage |
3.3% |
| Cough |
3.3% |
| Death |
3.3% |
| Mitochondrial Myopathy |
3.3% |
| Pleural Effusion |
3.3% |
| Red Blood Cell Abnormality |
3.3% |
| Renal Failure |
3.3% |
| Respiratory Depression |
3.3% |
| Sepsis |
3.3% |
|
| Secondary |
| Acute Promyelocytic Leukaemia |
29.1% |
| Myelodysplastic Syndrome |
26.4% |
| Acute Myeloid Leukaemia |
17.3% |
| Multiple Myeloma |
6.7% |
| Malignant Glioma |
4.8% |
| Product Used For Unknown Indication |
3.2% |
| Myelofibrosis |
2.7% |
| Pyrexia |
2.7% |
| Anxiety Disorder |
1.1% |
| Pain |
1.1% |
| Pneumocystis Jiroveci Pneumonia |
1.1% |
| Myeloid Leukaemia |
0.8% |
| Drug Use For Unknown Indication |
0.5% |
| Glioblastoma Multiforme |
0.5% |
| Nausea |
0.5% |
| Oral Herpes |
0.5% |
| Depression |
0.3% |
| Drug Withdrawal Syndrome |
0.3% |
| Mental Disorder |
0.3% |
| Prophylaxis |
0.3% |
|
| Pyrexia |
14.3% |
| White Blood Cell Count Decreased |
13.0% |
| Pneumonia |
9.1% |
| Electrocardiogram Qt Prolonged |
6.5% |
| Neutropenia |
6.5% |
| Anaphylactic Reaction |
5.2% |
| Sepsis |
5.2% |
| Thrombocythaemia |
5.2% |
| Leukopenia |
3.9% |
| Renal Failure Acute |
3.9% |
| Thrombocytopenia |
3.9% |
| Bacterial Sepsis |
2.6% |
| Hepatic Enzyme Increased |
2.6% |
| Herpes Zoster |
2.6% |
| Hypophosphataemia |
2.6% |
| Melaena |
2.6% |
| Off Label Use |
2.6% |
| Pancreatic Carcinoma |
2.6% |
| Pericardial Effusion |
2.6% |
| Protein Total Increased |
2.6% |
|
| Concomitant |
| Plasma Cell Myeloma |
31.1% |
| Acute Promyelocytic Leukaemia |
27.9% |
| Body Temperature Increased |
8.2% |
| Acute Myeloid Leukaemia |
6.6% |
| Arthralgia |
4.9% |
| Pyrexia |
4.9% |
| Anxiety Disorder |
3.3% |
| Chloroma |
3.3% |
| Myelodysplastic Syndrome |
3.3% |
| Chronic Myeloid Leukaemia |
1.6% |
| Metastases To Meninges |
1.6% |
| Pre-existing Disease |
1.6% |
| Product Used For Unknown Indication |
1.6% |
|
| Febrile Neutropenia |
11.1% |
| Infusion Related Reaction |
11.1% |
| Neuropathy Peripheral |
11.1% |
| Supraventricular Tachycardia |
11.1% |
| White Blood Cell Count Increased |
11.1% |
| Abdominal Pain |
5.6% |
| Bronchiectasis |
5.6% |
| Leukaemia Recurrent |
5.6% |
| Mitral Valve Incompetence |
5.6% |
| Obsessive-compulsive Disorder |
5.6% |
| Renal Impairment |
5.6% |
| Retinoic Acid Syndrome |
5.6% |
| Sepsis |
5.6% |
|
| Interacting |
| Product Used For Unknown Indication |
41.2% |
| Anxiety Disorder |
17.6% |
| Pyrexia |
11.8% |
| Acute Promyelocytic Leukaemia |
8.8% |
| Bipolar Disorder |
2.9% |
| Generalised Anxiety Disorder |
2.9% |
| Major Depression |
2.9% |
| Mental Disorder |
2.9% |
| Obsessive-compulsive Disorder |
2.9% |
| Panic Disorder |
2.9% |
| Pulmonary Embolism |
2.9% |
|
| Drug Interaction |
66.7% |
| Anxiety |
16.7% |
| Neutropenia |
16.7% |
|
